Studien im Bereich Klinische Marktforschung

Sleep behavior of the Swiss population: prevalence and  the day-time consequences of insomnia
Delini-Stula A, Bischof R, Holsboer-Trachsler E
Somnologie 11:193-201 (2007 Sep) : DOI 10.1007/s11818-007-0297-5
 

Therapeutic efficacy and acceptance of a new mirtazapine formulation (Remerol Soltab) in the treatment of depressed patients in the practice: the results of the swiss observational study
Delini-Stula A, Bischof R, Desax A, 2006, in preparation
 

The first experience with a mini-rating scale for the assessment of sexual functioning and life-satifaction in depressed patients in psychiatric practice
Fauchère P, Antonioli D, Mullor R, Bischof R, Delini-Stula A
Excli Journal. 2004 Aug;3:46-57
 

Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine
Hemmeter U, Annen B, Bischof R, Bruderlin U, Hatzinger M, Rose U, Holsboer-Trachsler E
Pharmacopsychiatry. 2001 Mar;34(2):50-9
 

Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers
Hemmeter U, Müller M, Bischof R, Annen B, Holsboer-Trachsler E
Psychopharmacology (Berl). 2000 Jan;147(4):384-96.
 

Microsleep during partial sleep deprivation in depression
Hemmeter U, Bischof R, Hatzinger M, Seifritz E, Holsboer-Trachsler E
Biol Psychiatry. 1998 Jun 1;43(11):829-39.
 

Treatment of sleep disturbance and pain syndrome in fibromyalgia patients with the 5-HT2-receptor antagonist ketanserine
U Hemmeter, R Kocher, M Hatzinger, E Seifritz, R Bischof, CJ Lauer
European Neuropsychpharmacology, 1996 Sep, Vol 6, Suppl 4
 

Brain Mapping als neurophysiologische Methode zur Objektivierung der antidepressiven Behandlung
Hemmeter U, Holsboer-Trachsler E, Bischof R, Kocher R
Jatros Neurologie 12 (1996) 11/Supplement
 

Sleep disorders in chronic pain and generalized tendomyopathy
Hemmeter U, Bischof R, Holsboer-Trachsler E
Schweiz Med Wochenschr. 1995 Dec 9;125(49):2391-7
 

Weitere Publikationen:

A day-to-day experience with Mirtazapine, a new NaSSA antidepressant, in the treatment of depressed patients in daily practice
A. Delini-Stula / R. Bischof / A. Desax
Abstract, European Neuropsychpharmacology, 2004 Oct, Vol 14, Supplement: 192
 

Antidepressant efficacy and patient’s acceptance of a new formulation of Mirtazipine in depressed patients in daily practice
Delini-Stula A, / Bischof R, Desax A
Abstract, European Neuropsychpharmacology, 2004 Oct, Vol 14, Supplement: 193
 

Sexual Dysfunctions and QoL in depressed patients during long term therapy with moclobemide and SSRI
P. Fauchère / D. Antonioli / R. Mullor / R. Bischof / A. Delini-Stula
Held on the 20th jubilary symposium of SSBP, January 13th 2000, Hotel Hilton, Basel
 

Die gemeinsame Behandlung von Schlafstörung und chronischem Schmerz mit dem 5-HT2-Rezeptor-Antagonisten Ketanserin bei generalisierter Tendomyopathie
Hemmeter U, Holsboer-Trachsler E, Lauer CJ, Bischof R, Kocher R
Poster, Fortschr. Neurol. Psychiatr. 64 SH 2 1996: 156
 

Die Einfluss von Mikroschlaf auf die Wirkung von partiellem Schlafentzug bei Patienten mit Depression
Hemmeter U, Hatzinger M, Seifritz E, Bischof R, Holsboer-Trachsler E
Poster, Fortschr. Neurol. Psychiatr. 64 SH 2 1996: 156